The study of effects of paliperidon extended-release tablets and olanzapine on metabolic profile

Trial Profile

The study of effects of paliperidon extended-release tablets and olanzapine on metabolic profile

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2013

At a glance

  • Drugs Paliperidone (Primary) ; Olanzapine
  • Indications Schizophrenia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 May 2013 Status changed from recruiting to completed according to results presented at the 166th Annual Meeting of the American Psychiatric Association.
    • 22 May 2013 Results presented at the 166th Annual Meeting of the American Psychiatric Association.
    • 20 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top